OHSU

Jeffrey Tyner, Ph.D.

Head Shot of Jeffrey Tyner
Email: 
click here

Selected Publications

"Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia," Clinical Cancer Research (Vol: 20, Issue: 8, Page 2092-2103) - 2014

"Functional integration of acute myeloid leukemia into the vascular niche," Leukemia - 2014

"Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization," Journal of Biological Chemistry (Vol: 289, Issue: 9, Page 5820-5827) - 2014

"PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma," Proceedings of the National Academy of Sciences of the United States of America (Vol: 111, Issue: 17, Page 6383-6388) - 2014

"Ponatinib overcomes FGF2-mediated resistance in CML patients without kinase domain mutations," Blood (Vol: 123, Issue: 10, Page 1516-1524) - 2014

 

Contact

  Email Jeffrey Tyner

503 346-0603